Vor Biopharma CEO Robert MBBS' 2022 pay jumps 172% to $4.5M
Vor Biopharma reports 2022 executive compensation
By ExecPay News
Published: April 14, 2023
Vor Biopharma reported fiscal year 2022 executive compensation information on April 14, 2023.
In 2022, three executives at Vor Biopharma received on average a compensation package of $2.9M, a 243% increase compared to previous year.
Average pay of disclosed executives at Vor Biopharma
Robert Ang, M.B.B.S, Chief Executive Officer, received $4.5M in total, which increased by 172% compared to 2021. 62% of MBBS' compensation, or $2.8M, was in option awards. MBBS also received $285K in non-equity incentive plan, $570K in salary, $857K in stock awards, as well as $21K in other compensation.
Nathan Jorgensen, Chief Financial Officer, received a compensation package of $2.2M, which increased by 302% compared to previous year. 51% of the compensation package, or $1.1M, was in option awards.
Tirtha Chakraborty, Chief Scientific Officer, earned $1.9M in 2022, a 250% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 14, 2023.